Aytu BioPharma, Inc. - AYTU Profit before deduction of interest, taxes, depreciation and amortization

Public company logo of Aytu BioPharma (AYTU)

The actual size of operating profit demonstrates that the current parameter equals 0.00. Sales of ADHD medications and the development of the consumer segment drive the business growth of Aytu BioPharma. However, the steady cash flow from pediatric drugs is stagnating, failing to generate long-term profit. Patent disputes, debt load, and high competition in specialized pharmacology exert additional pressure.

aytubio.com (AYTU) Operating profit EBITDA: for the period 11/23/2025 - 11/12/2026

Summary analytical data breakdowns for Aytu BioPharma (AYTU)

- stock value and consensus price forecast:
Market Chart Aytu BioPharma Inc|AYTU - Consensus Target
- issuer market value details:
Market Valuation Aytu BioPharma|AYTU - Enterprise Value
- book capitalization indicators:
Net Asset Value per Share Aytu BioPharma|AYTU - Book Capitalization|Capitalization to Book Value Ratio aytubio.com|AYTU - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Aytu BioPharma, Inc.|AYTU - Long-Term Debt to Equity|Current Liabilities to Equity Aytu BioPharma Inc|AYTU - Company Aggregate Debts|Debt to Net Assets Ratio Aytu BioPharma|AYTU - Company Long-Term Debts|Company Short-Term Debts Aytu BioPharma|Intermediate Coverage Ratio aytubio.com
- earnings and market multiples details:
AYTU - Company Net Income|Future Profit Aytu BioPharma, Inc.|AYTU - P/E Multiple|Forward P/E Multiple Aytu BioPharma Inc|AYTU - PEG Multiple|EV/EBITDA Multiple Aytu BioPharma|AYTU - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Aytu BioPharma|AYTU - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months aytubio.com|AYTU - Net earnings per share growth this year|Earnings growth forecast for next year Aytu BioPharma, Inc.
Summary company analytics:Aytu BioPharma, Inc.
Brand item of Aytu BioPharma

Patent-protected pediatric drugs and stringent FDA oversight drive the stability of cash flows for Aytu BioPharma (AYTU). By analyzing EBITDA volatility, an investor assesses the real operational efficiency of the business, stripped of non-cash charges and tax distortions, which allows the cash flow dynamics to reveal hidden stagnation or the resilience of the model during periods of market turbulence.

Who Aytu BioPharma, Inc. competes with

Operating income before deduction of amortization Vertex Corp (VRTX)|ALNY: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization INSM|UTHR: Operating profit EBITDA|Profit before interest, taxes and amortization BioMarin Pharmaceutical Inc. (BMRN)|BBIO (BridgeBio Pharma Inc) - Operating profit EBITDA|Operating profit before amortization BGM (BGM Group Corp)|Operating profit before deduction of amortization COGT (Cogent Biosciences)|XERS (xerispharma.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Keros Therapeutics, Inc. KROS|ARCT (Arcturus Therapeutics Inc) - Profit before deduction of interest, taxes, depreciation and amortization|Eton Pharma - Operating profit EBITDA|Income before deduction of interest, taxes and amortization KMDA (Kamada Pharma)|FULC: Operating profit EBITDA|Abeona Therapeutics Inc. (ABEO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Mereo BioPharma Group|PLX: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Pliant Therapeutics (PLRX)|Operating profit before deduction of amortization appliedtherapeutics.com APLT|Operating profit EBITDA RNTX (Rein Therapeutics Inc)|Operating profit EBITDA Gelteq Ltd GELS|Chemomab - Operating profit EBITDA|SRXH - Operating profit EBITDA|PLRZ (polyrizon-biotech.com) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization Aeterna Zentaris Inc. (AEZS)|Operating profit before deduction of amortization CYTH|INZY (Inozyme) - Company profit before taxes, interest and amortization|Operating profit before deduction of amortization RPHM (Reneo Pharmaceuticals, Inc.)|Operating profit EBITDA COSCIENS Biopharma Inc (CSCI)